[Adverse effects of subcutaneous administration of erythropoietin solution versus lyophilisate in patients receiving hemodialysis].

Source:http://linkedlifedata.com/resource/pubmed/id/8296408

Ugeskr. Laeg. 1994 Jan 10 156 2 183-4

Download in:

View as

General Info

PMID
8296408